Hillsdale Investment Management Inc. Horizon Therapeutics Public LTD CO Transaction History

Hillsdale Investment Management Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 29, 2021	SELL	$86.24 - $95.92 $3.64 Million - $4.05 Million	-42,220 Closed	0 $0
Q1 2021 Apr 22, 2021	SELL	$71.83 - $95.48 $2,154 - $2,864	-30 Reduced 0.07%	42,220 $3.89 Million
Q4 2020 Feb 09, 2021	SELL	$67.0 - $84.39 $824,100 - $1.04 Million	-12,300 Reduced 22.55%	42,250 $3.09 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $1.35 Million - $1.95 Million	-24,450 Reduced 30.95%	54,550 $4.24 Million
Q2 2020 Aug 11, 2020	SELL	$30.2 - $56.98 $1.44 Million - $2.72 Million	-47,700 Reduced 37.65%	79,000 $4.39 Million
Q1 2020 May 12, 2020	SELL	$24.87 - $38.56 $639,159 - $990,992	-25,700 Reduced 16.86%	126,700 $3.75 Million
Q4 2019 Feb 12, 2020	BUY	$25.43 - $36.67 $521,315 - $751,735	20,500 Added 15.54%	152,400 $5.52 Million
Q3 2019 Nov 13, 2019	SELL	$23.0 - $27.97 $57,500 - $69,925	-2,500 Reduced 1.86%	131,900 $3.59 Million
Q2 2019 Aug 02, 2019	BUY	$22.81 - $28.48 $203,009 - $253,472	8,900 Added 7.09%	134,400 $3.23 Million
Q1 2019 May 13, 2019	BUY	$19.49 - $29.01 $2.45 Million - $3.64 Million	125,500 New	125,500 $3.32 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.